Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases
Compare research vs pharmaceutical options
Theyre designing facilities that can adapt to changing regulations, support future product portfolios, and scale efficiently as opportunities emerge
When to increase dose Consider increasing if: Minimal response after 4-6 weeks at current dose No side effects at current dose Current dose below the higher end of recommended range Goals not being met with conservative approach Increase gradually, typically by 25-50% at a time
Why Small Molecule vs Peptide Matters in Adipose Research A practical research-design point: most metabolic research compounds in the broader catalog are peptides (Semaglutide, Tirzepatide, Retatrutide, Cagrilintide)
Check your jurisdiction and any sport-specific regulations